These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 20647975)

  • 1. Tuberculosis in renal transplant recipients: the evidence for prophylaxis.
    Currie AC; Knight SR; Morris PJ
    Transplantation; 2010 Oct; 90(7):695-704. PubMed ID: 20647975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective randomized control trial of isoniazid chemoprophylaxis during renal replacement therapy.
    Vikrant S; Agarwal SK; Gupta S; Bhowmik D; Tiwari SC; Dash SC; Guleria S; Mehta SN
    Transpl Infect Dis; 2005; 7(3-4):99-108. PubMed ID: 16390397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of isoniazid chemoprophylaxis in renal transplant recipients.
    Naqvi R; Naqvi A; Akhtar S; Ahmed E; Noor H; Saeed T; Akhtar F; Rizvi A
    Nephrol Dial Transplant; 2010 Feb; 25(2):634-7. PubMed ID: 19783599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycobacterium tuberculosis infection in renal transplant recipients.
    Ergun I; Ekmekci Y; Sengul S; Kutlay S; Dede F; Canbakan B; Erbay B
    Transplant Proc; 2006 Jun; 38(5):1344-5. PubMed ID: 16797298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic prophylaxis for preventing post solid organ transplant tuberculosis.
    Adamu B; Abdu A; Abba AA; Borodo MM; Tleyjeh IM
    Cochrane Database Syst Rev; 2014 Mar; 2014(3):CD008597. PubMed ID: 24590589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycobacterium tuberculosis infection in solid organ transplant recipients: experience from a single center in China.
    Zhang XF; Lv Y; Xue WJ; Wang B; Liu C; Tian PX; Yu L; Chen XY; Liu XM
    Transplant Proc; 2008 Jun; 40(5):1382-5. PubMed ID: 18589112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tuberculosis in renal transplant recipients: a Brazilian center registry.
    Guida JP; Bignotto Rosane D; Urbini-Santos C; Alves-Filho G; Ribeiro Resende M; Mazzali M
    Transplant Proc; 2009 Apr; 41(3):883-4. PubMed ID: 19376379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of isoniazid prophylaxis in renal allograft recipients.
    Naqvi R; Akhtar S; Noor H; Saeed T; Bhatti S; Sheikh R; Ahmed E; Akhtar F; Naqvi A; Rizvi A
    Transplant Proc; 2006 Sep; 38(7):2057-8. PubMed ID: 16979998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver transplantation without isoniazid prophylaxis for recipients with a history of tuberculosis.
    Nagai S; Fujimoto Y; Taira K; Egawa H; Takada Y; Kiuchi T; Tanaka K
    Clin Transplant; 2007; 21(2):229-34. PubMed ID: 17425750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isoniazid hepatotoxicity in renal transplant recipients.
    Antony SJ; Ynares C; Dummer JS
    Clin Transplant; 1997 Feb; 11(1):34-7. PubMed ID: 9067692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rifampicin plus pyrazinamide versus isoniazid for treating latent tuberculosis infection: a meta-analysis.
    Gao XF; Wang L; Liu GJ; Wen J; Sun X; Xie Y; Li YP
    Int J Tuberc Lung Dis; 2006 Oct; 10(10):1080-90. PubMed ID: 17044199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tuberculosis in systemic lupus erythematosus in an endemic area and the role of isoniazid prophylaxis during corticosteroid therapy.
    Mok MY; Lo Y; Chan TM; Wong WS; Lau CS
    J Rheumatol; 2005 Apr; 32(4):609-15. PubMed ID: 15801014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tuberculosis in Thai renal transplant recipients: a 15-year experience.
    Rungruanghiranya S; Ekpanyaskul C; Jirasiritum S; Nilthong C; Pipatpanawong K; Mavichak V
    Transplant Proc; 2008 Sep; 40(7):2376-9. PubMed ID: 18790239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tuberculosis in patients with systemic rheumatic or pulmonary diseases treated with glucocorticosteroids and the preventive role of isoniazid: a review of the available evidence.
    Falagas ME; Voidonikola PT; Angelousi AG
    Int J Antimicrob Agents; 2007 Dec; 30(6):477-86. PubMed ID: 17913470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No evidence for multiple-drug prophylaxis for tuberculosis compared with isoniazid alone in Southeast Asian refugees and migrants: completion and compliance are major determinants of effectiveness.
    MacIntyre CR; Ansari MZ; Carnie J; Hart WG
    Prev Med; 2000 May; 30(5):425-32. PubMed ID: 10845752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycobacterium tuberculosis in solid organ transplantation: incidence before and after expanded isoniazid prophylaxis.
    Al-Mukhaini SM; Al-Eid H; Alduraibi F; Hakami HI; Talhi HA; Shoukri M; Ahmed AM; Ahmed Y; Alrajhi AA
    Ann Saudi Med; 2017; 37(2):138-143. PubMed ID: 28377543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-tuberculosis prophylaxis following renal transplantation: acceptable variations?
    Field M; Clarke A; Kelleher M; Hamsho A; Mellor S; Ready A; Inston N; van Dellen D
    Transpl Infect Dis; 2012 Oct; 14(5):551-4. PubMed ID: 22321406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcome of isoniazid prophylaxis against tuberculosis in Chinese renal transplant recipients.
    Lui SL; Li FK; Choy BY; Chan TM; Lo WK; Lai KN
    Transpl Infect Dis; 2004 Mar; 6(1):55-6. PubMed ID: 15225230
    [No Abstract]   [Full Text] [Related]  

  • 19. The efficacy of isoniazid prophylaxis in renal transplant recipients in a high tuberculosis burden country.
    Dodani SK; Nasim A; Aziz T; Naqvi A
    Transpl Infect Dis; 2021 Oct; 23(5):e13709. PubMed ID: 34331355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycobacterium tuberculosis infection following renal transplantation in Taiwan.
    Chen CH; Lian JD; Cheng CH; Wu MJ; Lee WC; Shu KH
    Transpl Infect Dis; 2006 Sep; 8(3):148-56. PubMed ID: 16913973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.